Potent effects of dioscin against liver fibrosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Xiaoling ^a   Han, Xu ^a   Yin, Lianhong ^a   Xu, Lina ^a   Qi, Yan ^a   Xu, Youwei ^a   Sun, Huijun ^a   Lin, Yuan ^a   Liu, Kexin ^a   Peng, Jinyong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIOSCIN; DIOSGENIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; CELL AGING; DRUG EFFECTS; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELL; LIVER CELL; LIVER CIRRHOSIS; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; CELL AGING; DIOSGENIN; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELLS; HEPATOCYTES; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84927779859     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09713     Document Type: Article

References (55)

1. Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669 (2008).
2. Han, Y. P. et al. Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J Biol Chem 279, 4820-4828 (2004).
3. Mehal, W. Z., Iredale, J.&Friedman, S. L. Scraping fibrosis: expressway to the core of fibrosis. Nat Med 17, 552-553 (2011).
4. Parola, M., Marra, F. & Pinzani, M. Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med 29, 58-66 (2008).
5. Van Hul, N. K. et al. Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 49, 1625-1635 (2009).
6. Fallowfield, J. A. et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178, 5288-5295 (2007).
7. Poli, G. & Parola, M. Oxidative damage and fibrogenesis. Free Radic Biol Med 22, 287-305 (1997).
8. Shimizu, I. et al. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29, 149-160 (1999).
9. Inagaki, Y. & Okazaki, I. Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56, 284-292 (2007).
10. Verrecchia, F. & Mauviel, A. Transforming growth factor-b and fibrosis. World J Gastroenterol 13, 3056-3062 (2007).
11. Cheng, J. H. et al.Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 294, G39-49 (2008).
12. Xi, L. et al. C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology 53, 127-135 (2011).
13. Wright, M. C. et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121, 685-698 (2001).
14. Campisi, J. & d'Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8, 729-740 (2007).
15. Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667 (2008).
16. Muddu, A. K., Guha, I. N., Elsharkawy, A. M. &Mann, D. A. Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic. Int J Biochem Cell Biol 39, 695-714 (2007).
17. Balunas, M. J.& Kinghorn, A.D.Drug discovery from medicine plants. Life Sci 78, 431-441 (2005).
18. Dong, h., Lu, F. & Zhao, L. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Chin J Integr Med 18, 152-160 (2012).
19. Li, X. et al. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med 60, 168-176 (2013).
20. Wang, X. et al. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol 55, 379-387 (2011).
21. Huang, Q. et al. Protective effect of genistein isolated from Hydrocotyle sibthorpioides on hepatic injury and fibrosis induced by chronic alcohol in rats. Toxicol Lett 217, 102-110 (2013).
22. Brautbar, N. &Williams, J. Industrial solvents and liver toxicity: risk assessment, risk factors and mechanisms. Int J Hyg Environ Health 205, 479-491 (2002).
23. Hsieh, M. J. et al. Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines. Arch Toxicol 87, 1927-1937 (2013).
24. Lu, B. N., Yin, L. H., Xu, L. N. & Peng, J. Y. Application of proteomic and bioinformatic techniques for studying the hepatoprotective effect of dioscin against CCl4-induced liver damage in mice. Planta Med 77, 407-415 (2011).
25. Sautour, M. et al. A new steroidal saponin from Dioscorea cayenensis. Chem Pharm Bull 52, 1353-1355 (2004).
26. Kaskiw, M. J. et al. Structural analogues of diosgenyl saponins: synthesis and anticancer activity. Bioorg Med Chem 17, 7670-7679 (2009).
27. Xu, T. T. et al. Protective effects of dioscin against alcohol-induced liver injury. Arch Toxicol 88, 739-753 (2014).
28. Xu, L. N. et al. iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats. RSC Adv 4, 30704-30711 (2014).
29. Zhao, X. M. et al. Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo. Toxicol Lett 214, 69-80 (2012).
30. Bataller, R. & Brenner, D. A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 21, 437-451 (2001).
31. Park, J. K. et al. Vitamin C Deficiency Attenuates Liver Fibrosis by Way of Up-regulated Peroxisome Proliferator-Activated Receptor-gamma Expression in Senescence Marker Protein 30 Knockout Mice. Hepatology 51, 1766-1777 (2010).
32. Yu, J. et al. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice. Biochem Biophys Res Commun 372, 571-577 (2008).
33. Nagase, H. & Woessner, J. F. Matrix metalloproteinases. J Biol Chem 274, 21491-21494 (1999)
34. Liu, Y. et al. Inhibition of PDGF, TGF-b, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 55, 612-625 (2011).
35. Green, D. R. & Kroemer, G. The pathophysiology of mitochondrial cell death. Science 305, 626-629 (2004).
36. Youle, R. J. & Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47-59 (2008).
37. Novo, E. et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 55, 1174-1182 (2006).
38. Malhi, H., Gores, G. J. & Lemasters, J. J. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43, S31-S44 (2006).
39. Myung, S. J. et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett 581, 2954-2958 (2007).
40. Bataller, R., Rombouts, K., Altamirano, J. & Marra, F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol 25, 231-244 (2011).
41. Stienstra, R. et al. Kupffer cells promote hepatic steatosis via interleukin-1 beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 51, 511-522 (2009).
42. Fox, E. S., Kim, J. C. & Tracy, T. F. NF-kappaB activation and modulation in hepatic macrophages during cholestatic injury. J Surg Res 72, 129-134 (1997).
43. Liu, Y. et al. Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258. Lab Invest 89, 1152-1160 (2009).
44. Wang, Y. et al. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53, 132-144 (2010).
45. Su, J. L., Lin, M. T. & Hong, C. C. Resveratrol induces Fas L-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signalling pathway in human leukaemia HL-60 cells. Carcinogenesis 26, 1-10 (2005).
46. Soh, Y., Jeong, K. S. & Lee, I. J. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12. Cells Mol Pharmacol 58, 535-541 (2000).
47. Hu, M.M. et al. Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J Appl Toxicol 33, 712-722 (2013).
48. Yin, L. H. et al. An economical method for isolation of dioscin from dioscorea nipponica makino by HSCCC coupled with ELSD, and a computer-aided UNIFAC mathematical model. Chromatographia 71, 15-23 (2009).
49. Dong, D. S. et al. Protective effects of the total saponins from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food Chem Toxicol 62, 120-130 (2013).
50. Zhang, S. et al. Effects of flavonoids from Rosa laevigata Michx fruit against highfat diet-induced non-alcoholic fatty liver disease in rats. Food Chem 141, 2108-2116 (2013).
51. Xu, L. et al.Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54, 142-151 (2005).
52. Vogel, S. et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41, 882-893 (2000).
53. Weiskirchen, R. & Gressner, A. M. Isolation and culture of hepatic stellate cells. Methods Mol Med 117, 99-113 (2005).
54. Ikejima, K. et al. Hepatocyte growth factor inhibits intercellular communication via gap junctions in rat hepatocytes. Biochem Biophys Res Commun 214, 440-446 (1995).
55. Pitrak, D. L. et al . Accelerated neutrophil apoptosis in the acquired immunode-ficiency syndrome. J Clin Invest 98, 2714-2719 (1996).